TransMedics Group, Inc. (TMDX)
66.13
-2.21
(-3.23%)
USD |
NASDAQ |
May 19, 16:00
66.60
+0.47
(+0.71%)
After-Hours: 20:00
TransMedics Group Research and Development Expense (Quarterly) : 24.88M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Stereotaxis, Inc. | 2.397M |
| CONMED Corp. | 16.33M |
| Escalon Medical Corp. | 0.0299M |
| IRIDEX Corp. | 0.905M |
| Electromed, Inc. | 0.361M |